Evidence map›Paper›PMID 24771768›Full record

ArticleeLife2014

Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network.

Jerome C Nwachukwu, Sathish Srinivasan, Nelson E Bruno, Alexander A Parent, Travis S Hughes, Julie A Pollock, Olsi Gjyshi, Valerie Cavett, Jason Nowak, Ruben D Garcia-Ordonez and 6 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 2 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 2 syntheses or guidelines pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Anti-Inflammatory Properties of Resveratrol.International journal of molecular sciences · 2025
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Asymmetric allostery in estrogen receptor-α homodimers drives responses to the ensemble of estrogens in the hormonal milieu.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Food Antioxidants and Their Interaction with Human Proteins.Antioxidants (Basel, Switzerland) · 2023
    Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Jerome C NwachukwuDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, United States.
Sathish SrinivasanDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, United States.
Nelson E BrunoDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, United States.
Alexander A ParentDepartment of Chemistry, University of Illinois, Urbana, United States.
Travis S HughesDepartment of Molecular Therapeutics, The Scripps Research Institute, Jupiter, United States.
Julie A PollockDepartment of Chemistry, University of Illinois, Urbana, United States.
Olsi GjyshiDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, United States.
Valerie CavettDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, United States.
Jason NowakDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, United States.
Ruben D Garcia-OrdonezDepartment of Molecular Therapeutics, The Scripps Research Institute, Jupiter, United States.
René HoutmanNuclear Receptor Group, PamGene International, Den Bosch, Netherlands.
Patrick R GriffinDepartment of Molecular Therapeutics, The Scripps Research Institute, Jupiter, United States.
Douglas J KojetinDepartment of Molecular Therapeutics, The Scripps Research Institute, Jupiter, United States.
John A KatzenellenbogenDepartment of Chemistry, University of Illinois, Urbana, United States.
Michael D ConkrightDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, United States.
Kendall W NettlesDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, United States knettles@scripps.edu.
Scripps Research Institute · USUniversity of Illinois Urbana-Champaign · USPamGene (Netherlands) · NL

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Research Training Program in Toxicology and Environmental HealthT32ES007326 · NIEHS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI Jodi A. Flaws · 2000 to 2026
$8.7M
MOLECULAR PROBES FOR STEROID RECEPTORSR37DK015556 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KATZENELLENBOGEN, JOHN A. · 1987 to 2012
$4.4M
Structural features of the nuclear receptor signaling codeU01GM102148 · NIGMS · SCRIPPS FLORIDA · PI NETTLES, KENDALL W · 2012 to 2014
$2.7M
Regulation of NFkappaB activity by the Estrogen ReceptorR01DK077085 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI NETTLES, KENDALL W · 2008 to 2012
$2.1M
Structure and Function of Alternate-Site Binding of Anti-Diabetic PPARG LigandsR01DK101871 · NIDDK · SCRIPPS FLORIDA · PI KOJETIN, DOUGLAS · 2014 to 2018
$2.1M
Novel Ligands and Mechanisms to Achieve Selective Nuclear Receptor ActivityR01DK015556 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KATZENELLENBOGEN, JOHN A. · 1986 to 2016
$1.6M
Structural mechanism and function of endogenous ligands targeting orphan NR4A receptorsR01GM114420 · NIGMS · SCRIPPS FLORIDA · PI KOJETIN, DOUGLAS · 2015 to 2018
$1.5M
Molecular Analysis of Steroid Hormone Receptors with X-ray CrystallographyR33CA132022 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI NETTLES, KENDALL W · 2008 to 2010
$1.1M
Small-Molecule Disruptors of the Nuclear Hormone Receptor/Coactivator InteractionF30DK083899 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI PARENT, ALEXANDER ALPHONSE · 2009 to 2013
$234k
Linking partial and non-agonist induced dynamics to PPAR gamma functionsF32DK097890 · NIDDK · SCRIPPS FLORIDA · PI HUGHES, TRAVIS SHANE · 2012 to 2013
$110k
NCI NIH HHS 5R33CA132022NCI NIH HHS R33 CA132022NIDDK NIH HHS 5R37DK015556NIDDK NIH HHS F30 DK083899NIDDK NIH HHS F30DK083899NIDDK NIH HHS F32 DK097890NIDDK NIH HHS F32DK097890NIDDK NIH HHS R01 DK015556NIDDK NIH HHS R01 DK077085NIDDK NIH HHS R01 DK101871NIDDK NIH HHS R01DK101871NIDDK NIH HHS R37 DK015556NIEHS NIH HHS T32 ES007326NIEHS NIH HHS T32ES007326NIGMS NIH HHS 1U01GM102148NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R01 GM114420NIGMS NIH HHS U01 GM102148
6 · The paper itself

Abstract

Resveratrol has beneficial effects on aging, inflammation and metabolism, which are thought to result from activation of the lysine deacetylase, sirtuin 1 (SIRT1), the cAMP pathway, or AMP-activated protein kinase. In this study, we report that resveratrol acts as a pathway-selective estrogen receptor-α (ERα) ligand to modulate the inflammatory response but not cell proliferation. A crystal structure of the ERα ligand-binding domain (LBD) as a complex with resveratrol revealed a unique perturbation of the coactivator-binding surface, consistent with an altered coregulator recruitment profile. Gene expression analyses revealed significant overlap of TNFα genes modulated by resveratrol and estradiol. Furthermore, the ability of resveratrol to suppress interleukin-6 transcription was shown to require ERα and several ERα coregulators, suggesting that ERα functions as a primary conduit for resveratrol activity.DOI: http://dx.doi.org/10.7554/eLife.02057.001.

Indexed as

Adenylate KinaseCyclic AMPEstrogen Receptor alphaFemaleHumansInflammationInterleukin-6LigandsMCF-7 CellsPromoter Regions, GeneticProtein ConformationResveratrolSignal TransductionStilbenesTumor Necrosis Factor-alphaAdenylate KinaseCyclic AMPEstrogen Receptor alphaInterleukin-6LigandsResveratrolStilbenesTumor Necrosis Factor-alphaestrogen receptorinflammationresveratroltranscription regulationx-ray crystallography

Identifiers

PMID24771768
PMCPMC4017646
OpenAlexW2145474242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.